The results (Figure 4) show that high expression of ZNF224 is associated with shorter TTFT, indicating a possible negative impact of high ZNF224 expression levels on clinical evolution in CLL. This evidence concerns the gene ZNF224 and B-cell chronic lymphocytic leukemia.